April 25, 2017

Dr. John Dick presented with CIHR Gold Leaf Award for Discovery

Dr. John Dick

Dr. John Dick was recognized for his pioneering research in cancer stem cells with the presentation of the CIHR Gold Leaf Award for Discovery. He was the first scientist in the world to confirm their existence. Better understanding of cancer stem cells has the potential to lead to new treatments, ultimately resulting in improved patient outcomes.

Continue reading – Dr. John Dick presented with CIHR Gold Leaf Award for Discovery

December 7, 2016

Cancer stem cell scientists create tool to aid in planning treatment for leukemia

Acute myeloid leukemia (AML) is the most common form of acute leukemia in adults and is one of the most deadly. Although AML is treated as a single disease, patient response to intensive curative-intent chemotherapy varies. It is currently difficult to predict who will do well with standard treatment, and who will not benefit from standard treatment and might do better enrolling in a clinical trial where they may be offered novel therapies.

Continue reading – Cancer stem cell scientists create tool to aid in planning treatment for leukemia

August 9, 2016

Patients need access to more stem cells for transplants. Researchers have now identified the genetic switch that could turn on the supply

DSC_3341

 

Researchers at the Princess Margaret Cancer Centre, funded in part by OICR, have found a genetic switch that could be used to develop many more stem cells from the blood found in umbilical cords, a resource that is highly valuable for stem cell transplants but still in short supply.

Continue reading – Patients need access to more stem cells for transplants. Researchers have now identified the genetic switch that could turn on the supply